Erlotinib is an epidermal growth factor receptor inhibitor. Erlotinib binds in a reversible fashion to the adenosine triphosphate (ATP) binding site of the receptor.

248594-19-6

C23H27N3O7S

489.54

埃罗替尼甲磺酸盐;CP358774;OSI-774;OSI 774;CP-358,774;CP-358774;Erlotinib mesylate

(< 1 mg/ml refers to the product slightly soluble or insoluble )
Powder: -20°C for 3 years
In solvent: -80°C for 2 years